Skip to main content
. 2022 Feb 14;10(2):446. doi: 10.3390/biomedicines10020446

Figure 9.

Figure 9

Immunoreactivity of alpha smooth muscle actin (α-SMA) and results of a terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay in the hippocampus in the NT and VD groups (NT [normal type]: control group, VD [vascular dementia]: BCAS [bilateral carotid artery stenosis] model group). (A,B) Left: representative photomicrographs of α-SMA in TUNEL immunoreactive cells. Right: quantification of α-SMA through TUNEL immunoreactivity.